As global demand for personalised and effective healthcare rises, the Department of Health – Abu Dhabi (DoH) is preparing to host Abu Dhabi Global Health Week (ADGHW) from April 15–17, 2025, bringing together top minds in healthcare, technology, research, and policy to focus on enhancing both lifespan and healthspan.
Global Longevity and Precision Medicine Initiative Unveiled
One of the major highlights of the event will be the launch of a global initiative focused on longevity science and precision medicine. The initiative is expected to spark international collaboration and innovation in next-generation medical technologies. Its goal: to drive wider adoption of personalised healthcare solutions that improve health outcomes and extend healthy life expectancy.
This comes at a crucial time—while global life expectancy has risen to 71 years, people still spend an average of 9.6 years in poor health due to chronic illnesses, underlining the urgency for solutions that prioritise not just living longer, but living healthier.
A Vision for Intelligent, Global Healthcare
Ahead of the event, H.E. Mansoor Ibrahim Al Mansoori, Chairman of DoH, stated,
“We’re focused on delivering personalised, preventative care that helps people live healthier and more fulfilling lives. We’re inviting the world to join us in co-creating the next era of health—powered by data, driven by collaboration, and enabled by transformative technology like AI.”
Abu Dhabi’s proactive approach to healthcare innovation is backed by world-class institutions, AI-driven research, and strategic global partnerships. The emirate is positioning itself as a leader in healthcare transformation through initiatives that promote equitable access to cutting-edge treatments and disease prevention strategies.
Tangible Progress on the Ground
Abu Dhabi’s commitment to longevity is already showing results. The emirate recently licensed the Institute for Healthier Living Abu Dhabi (IHLAD)—the first of its kind globally—as a Healthy Longevity Medicine Centre. This centre delivers AI-enabled, personalised care designed to extend healthy lifespan, manage chronic conditions, and support mental well-being.
This was followed by the launch of the Healthy Longevity Innovation Forum and the region’s first regulatory framework for longevity-focused medical centres, setting a new benchmark for governance in healthcare innovation.
Initiative Highlights
During ADGHW, the longevity and precision health initiative will include:
- A global consensus document on longevity and precision medicine
- Commitments from international stakeholders to adopt AI-powered healthcare solutions
- Frameworks for integrating genomics-based care into standard medical practices
- Policy guidelines to accelerate innovation while ensuring safety and equity
- Strategies to promote ethical and accessible healthcare innovation worldwide
ADGHW 2025: Where the World Connects for Health Innovation
ADGHW 2025 will host more than 15,000 visitors, 1,900 delegates, 200 speakers, and 150 exhibitors from over 90 countries. Organised under the theme ‘Towards Longevity: Redefining Health and Well-being’, the event is designed as an inclusive platform for dialogue, collaboration, and action.
Key themes for this year’s gathering include:
- Longevity & Precision Health
- Health System Resilience & Sustainability
- Digital Health & AI
- Investment in Life Sciences
The event will feature workshops, panel discussions, networking sessions, and showcases of breakthrough innovations from across the globe.
A Year-Round Platform with Global Impact
Beyond the three-day event, Abu Dhabi Global Health Week serves as an “always-on” platform, empowering a community of researchers, innovators, policymakers, and investors to turn ideas into action. It encourages a shift towards proactive, personalised, and holistic care models.
The 2025 edition is powered by key strategic partners, including Foundation Partner M42 and Global Health and Longevity Champion PureHealth, with support from leading sponsors such as Burjeel, GSK, Johnson & Johnson, Lilly, Microsoft, Pfizer, Roche, Novo Nordisk, Novartis, and others.
